速尿及其两种活性代谢物在人体中的药代动力学。 - Suppr

Suppr

超能文献

Pharmacokinetics of mefruside and two active metabolites in man.

作者信息

Fleuren H L, Verwey-van Wissen C P, van Rossum J M

出版信息

Eur J Clin Pharmacol. 1980 Jan;17(1):59-69. doi: 10.1007/BF00561678.

DOI:10.1007/BF00561678

PMID:7371701

Abstract

摘要

相似文献

Pharmacokinetics of mefruside and two active metabolites in man.速尿及其两种活性代谢物在人体中的药代动力学。

Eur J Clin Pharmacol. 1980 Jan;17(1):59-69. doi: 10.1007/BF00561678.

Quantitative gas chromatographic determination of two oxidized metabolites of the diuretic mefruside in human urine, plasma and red blood cells.采用气相色谱法定量测定人尿液、血浆和红细胞中利尿剂美夫西特的两种氧化代谢物。

J Chromatogr. 1980 May 9;182(2):179-90. doi: 10.1016/s0378-4347(00)81622-9.

Determination of mefruside and its metabolites in urine by high performance liquid chromatography.高效液相色谱法测定尿液中甲氯噻嗪及其代谢物

Anal Chem. 1977 Aug;49(9):1311-3. doi: 10.1021/ac50017a007.

Fate of [14C]-bumetanide in man.[14C] -布美他尼在人体中的代谢情况。

Br J Clin Pharmacol. 1977 Feb;4(1):39-44. doi: 10.1111/j.1365-2125.1977.tb00664.x.

Effects of mefruside treatment in hypertension.速尿治疗高血压的效果。

Acta Med Scand. 1980;208(4):272-8.

Quantitative gas chromatographic determination of mefruside in body fluids by extractive methylation and nitrogen detection.通过萃取甲基化和氮检测对体液中速尿进行气相色谱定量测定。

Arzneimittelforschung. 1979;29(7):1041-7.

Diuretics.利尿剂

S Afr Med J. 1981 Jan 3;59(1):9-13.

[Correlations between blood pressure, blood volume and plasma renin during therapy with diuretics in essential hypertension. Comparison between the mineralocorticoid antagonist spironolactone and the "loop" diuretic mefruside].[原发性高血压患者使用利尿剂治疗期间血压、血容量与血浆肾素之间的相关性。盐皮质激素拮抗剂螺内酯与“袢”利尿剂美夫西特的比较]

Schweiz Med Wochenschr. 1977 Jan 29;107(4):104-15.

Pharmacokinetics of a new diuretic, torasemide, in man.新型利尿剂托拉塞米在人体中的药代动力学

Arch Int Pharmacodyn Ther. 1981 Feb;249(2):322-5.

[Alternatives to digitalis therapy: diuretics].

Verh Dtsch Ges Inn Med. 1977;83:148-54.

本文引用的文献

Studies with chlorothiazide tagged with radioactive carbon (C14) in human beings.

Arch Intern Med. 1960 Jul;106:57-63. doi: 10.1001/archinte.1960.03820010059010.

The binding of aromatic sulfonamides to erythrocytes.芳香族磺酰胺与红细胞的结合。

Biochem Pharmacol. 1961 Apr;6:21-46. doi: 10.1016/0006-2952(61)90066-1.

The mechanism of action of chlorothiazide.氯噻嗪的作用机制。

Ann N Y Acad Sci. 1958 Feb 3;71(4):363-79. doi: 10.1111/j.1749-6632.1958.tb46763.x.

J Chromatogr. 1980 May 9;182(2):179-90. doi: 10.1016/s0378-4347(00)81622-9.

[Concentration in plasma and clearane of N-(4'-chlore-3'-sulfameyl-benzelsulfenyl)-N-methyl-2-aminomethyl-2-methyl-tetrahydrefuran and N-(4'-chlore-3'-sulfameyl-benzelsulfenyl)-N-methyl-2-aminemethyl-2-methyl-5-exe-tetrahydrofuran].N-（4'-氯-3'-磺胺基-苯基亚磺酰基）-N-甲基-2-氨甲基-2-甲基-四氢呋喃和N-（4'-氯-3'-磺胺基-苯基亚磺酰基）-N-甲基-2-氨甲基-2-甲基-5-己基-四氢呋喃的血浆浓度及清除率

Arzneimittelforschung. 1967 Jun;17(6):688-91.

[Studies with C14-labelled N-(4'-chlore-3'-sulfameyl-benzelsulfeny)-N-methyl-2-aminomethyl-2-methyl-tetrahydrefuran. Metabolism and kinetics].

Arzneimittelforschung. 1967 Jun;17(6):672-87.

[Pharmacology of N-(4'-chlore-3'-sulfameyl-benzelsulfenyl)-N-methyl-2-aminomethyl-2-methyl-tetrahydrefuran, a new diuretically active compound].新型利尿活性化合物N-（4'-氯-3'-磺胺基苯基亚磺酰基）-N-甲基-2-氨甲基-2-甲基四氢呋喃的药理学

Arzneimittelforschung. 1967 Jun;17(6):659-71.

[Chemical structure and diuretic effect in the series of 4-chloro-3-sulfonamide-benzolsulfonamide].[4-氯-3-磺酰胺基苯磺酰胺系列的化学结构与利尿作用]

Arzneimittelforschung. 1967 Jun;17(6):653-9.

The acute effects of mefruside in man: a new diuretic compound.速尿对人体的急性作用：一种新型利尿化合物。

J Pharmacol Exp Ther. 1970 Feb;171(2):288-99.

Pharmacokinetics of metolazone in normal subjects and in patients with cardiac or renal failure.

Clin Pharmacol Ther. 1974 Aug;16(2):322-9. doi: 10.1002/cpt1974162322.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验